🔍

MAXIND - Max India Ltd

📊 NSE: MAXIND 🏢 Finance & Investments 📅 Last Updated: 12/14/2025 9:41

📢 Recent Corporate Announcements

Max India to Participate in Arihant Capital Conference on March 11, 2026

🟡 NEUTRAL ⭐ 3/10

ROUTINE 📅 02 Mar 2026, 04:54 PM

Max India Limited has announced its participation in the Arihant Capital Conference scheduled for March 11, 2026, starting at 10:00 AM. The meeting will be held virtually and involves interactions with various analysts and institutional investors. The company will utilize the Investor Presentation previously filed with the exchanges on February 20, 2026, for these discussions. Management has explicitly stated that no unpublished price-sensitive information (UPSI) will be shared during the event.

Virtual meeting scheduled for March 11, 2026, at 10:00 AM onwards.
Participation in the Arihant Capital Conference to engage with institutional investors.
Discussions to be based on the Investor Presentation uploaded on February 20, 2026.
Compliance with SEBI Regulation 30 regarding disclosure of investor meets.
No unpublished price-sensitive information (UPSI) intended to be discussed.

💡 Investors should review the February 20, 2026, investor presentation to understand the company's current trajectory, as no new material information is expected from this routine meet.

Max India Proposes ₹3 Cr Chairman Pay and 1.1 Million ESOP Pool Expansion

🟡 NEUTRAL ⭐ 6/10

MANAGEMENT 📅 20 Feb 2026, 08:08 PM

Max India Limited has issued a postal ballot notice seeking shareholder approval for two key special resolutions. The first resolution proposes an annual compensation of ₹3 crore for Non-Executive Chairman Mr. Analjit Singh for FY 2026-27, which exceeds 50% of the total remuneration for all non-executive directors. The second resolution seeks to expand the 2020 Employee Stock Option Plan (ESOP) pool by 1.1 million options, increasing the total pool to 3,789,313 options. Shareholders can participate in remote e-voting from February 21 to March 22, 2026.

Proposed annual compensation of ₹3,00,00,000 for Non-Executive Chairman Mr. Analjit Singh for FY 2026-27.
Increase in ESOP 2020 pool size by 11,00,000 options, bringing the total to 3,789,313 options.
Chairman's proposed pay exceeds 50% of the total annual remuneration payable to all Non-Executive Directors.
Remote e-voting period scheduled from February 21, 2026, to March 22, 2026, with a cut--off date of February 13, 2026.

💡 Investors should evaluate the potential equity dilution from the 1.1 million additional ESOPs and review the justification for the Chairman's compensation. It is advisable to monitor the voting results to understand institutional sentiment regarding these governance and incentive proposals.

Max India's Antara Care Homes Revenue Grows 2.4x YoY; Bed Capacity Reaches 485

🟢 POSITIVE ⭐ 7/10

EXPANSION 📅 20 Feb 2026, 04:54 PM

Max India's senior care brand, Antara, reported a strong 2.4x YoY growth in Care Homes revenue to Rs 5.0 crore for Q3FY26. The company has successfully scaled its capacity to 485 beds across NCR, Bangalore, and Chennai, while its senior residence projects in Noida and Gurugram are fully sold out. Antara is positioning itself to lead the Indian senior care market, which is projected to reach USD 33 billion by 2030. The company aims to add 1.5 million sq. ft. of senior living space annually to capitalize on the rising demand for organized senior care.

Care Homes net revenue increased 2.4x YoY to Rs 5.0 crore in Q3FY26 with an ARPOB of approximately Rs 6,500.
Operational bed capacity reached 485 beds across 4 cities, with occupancy improving to 27% in Q3FY26.
Senior residence inventory of ~650 units in Noida and Gurugram is 100% sold out, with Noida ready for possession.
AGEasy product vertical has served over 6.5 lakh customers since its 2023 launch, offering 180+ SKUs for chronic condition management.
The company targets a development pace of 1.5 million sq. ft. per year to address a market with only 1.3% current penetration.

💡 Investors should track the occupancy rates of the newly launched Care Homes in Chennai and Bangalore as a key driver for profitability. The company's ability to execute its 1.5 million sq. ft. annual expansion plan will be critical for long-term value creation in the niche senior care segment.

Max India Q3 Revenue Grows 27% to ₹49.8 Cr; Targets Consolidated Profitability by FY28

🟢 POSITIVE ⭐ 7/10

EARNINGS 📅 16 Feb 2026, 06:41 PM

Max India reported a 27% YoY increase in Q3 FY26 revenue to ₹49.8 crore, supported by strong momentum in its Antara Senior Living and Assisted Care verticals. While consolidated EBITDA remains negative at ₹29 crore due to expansion costs, the company has a clear roadmap to reach breakeven for its key business units by FY27. The residential segment is performing well with the successful launch of Estate 361 in Gurgaon, securing 100 bookings in Phase 1 within two months. Management maintains a healthy liquidity position with ₹105 crore in treasury assets to fund its growth towards consolidated profitability by FY28.

Q3 FY26 revenue increased 27% YoY to ₹49.8 crore; 9M FY26 revenue grew 19% to ₹141.3 crore.
Estate 361 Phase 1 launched in Dec '25 with 100 of 180 units already booked; management fee of ₹28.2 crore earned from Estate 360 since inception.
Assisted Care bed capacity reached 485 with occupancy improving to 27% in Q3 FY26 from 25% in Q2.
AGEasy 9M revenue grew 2.3x YoY to ₹54 crore, with exit gross margins improving to 46% in December 2025.
Company targets breakeven for Residences and AGEasy by FY27, with consolidated profitability expected in FY28.

💡 Investors should focus on the execution of the 1.5 million sq. ft. residential pipeline and the occupancy ramp-up in Assisted Care as key triggers for the FY27 breakeven target. The stock remains a strategic long-term play on India's organized senior care market.

Max India Releases Audio Recording of Q3 & 9M FY26 Earnings Conference Call

🟡 NEUTRAL ⭐ 3/10

ROUTINE 📅 10 Feb 2026, 09:20 PM

Max India Limited has informed the stock exchanges that the audio recording of its earnings conference call held on February 10, 2026, is now available. The call involved senior management discussing the company's financial performance for the third quarter and nine months ended December 31, 2025. This disclosure is a standard regulatory requirement under SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. Investors can access the recording via the company's website to gain deeper insights into management's commentary and future outlook.

Earnings conference call conducted on February 10, 2026, following Q3 results.
Management discussed performance for the 9-month period ending December 31, 2025.
Audio recording link provided for public access on the company's official website.
Compliance filing submitted to both BSE and NSE under Regulation 30.

💡 Investors should listen to the recording to understand management's guidance on the senior living sector and operational updates. No immediate trading action is required based solely on this procedural filing.

Max India Reports Zero Deviation in Utilization of ₹124.23 Cr Rights Issue Proceeds

🟡 NEUTRAL ⭐ 4/10

REGULATORY 📅 10 Feb 2026, 05:08 PM

Max India Limited has submitted its statement of deviation for the quarter ended December 31, 2025, confirming that funds raised via its Rights Issue are being used as intended. The company raised ₹124.23 Crores on May 23, 2025, based on the objects stated in the Letter of Offer dated April 25, 2025. The monitoring agency, CARE Ratings Limited, and the Audit Committee have reviewed the utilization and found no discrepancies. This filing ensures transparency regarding the deployment of capital raised from shareholders.

Confirmed zero deviation or variation in the utilization of ₹124.23 Crores raised through Rights Issue
Funds were raised on May 23, 2025, following the Letter of Offer dated April 25, 2025
CARE Ratings Limited served as the external monitoring agency for the fund deployment
The statement covers the third quarter of the 2025-26 fiscal year ending December 31, 2025

💡 Investors should note the company's adherence to its stated capital allocation plan, which reflects good corporate governance. No immediate action is required as the funds are being deployed according to the original prospectus.

Max India Announces Resignation of Independent Director and Relocation of Registered Office

🟡 NEUTRAL ⭐ 4/10

MANAGEMENT 📅 10 Feb 2026, 04:35 PM

Max India Limited has announced the resignation of Mrs. Sharmila Tagore as a Non-Executive Independent Director, effective February 10, 2026, citing increased personal commitments. Consequently, she will also vacate her positions on the Audit Committee and the Nomination and Remuneration Committee. In a separate administrative move, the company is shifting its registered office from Mumbai to New Delhi, effective February 15, 2026. These decisions were finalized during a board meeting that concluded at 15:40 hrs on February 10.

Resignation of Mrs. Sharmila Tagore as Non-Executive Independent Director effective Feb 10, 2026
Director ceases to be a member of the Audit and Nomination and Remuneration Committees
Registered office shifting from Mumbai to Okhla, New Delhi, effective Feb 15, 2026
Director confirmed no other material reasons for resignation beyond personal commitments

💡 These are routine administrative and board changes with no direct impact on business operations or financials. Investors should simply monitor for the appointment of a new independent director to maintain board compliance.

Max India: Resignation of Independent Director Sharmila Tagore and Registered Office Relocation

🟡 NEUTRAL ⭐ 4/10

MANAGEMENT 📅 10 Feb 2026, 04:31 PM

Max India Limited has announced the resignation of Mrs. Sharmila Tagore as a Non-Executive Independent Director, effective February 10, 2026, citing increased personal commitments. Following her departure, she will also cease to be a member of the company's Audit Committee and Nomination and Remuneration Committee. Additionally, the Board has approved shifting the company's registered office from Mumbai to New Delhi, effective February 15, 2026. These administrative and board-level changes were confirmed in a meeting held on February 10, 2026.

Mrs. Sharmila Tagore resigned as Non-Executive Independent Director effective February 10, 2026.
The resignation results in a vacancy in the Audit and Nomination and Remuneration Committees.
Registered office shifting from Mumbai to Max House, Okhla, New Delhi effective February 15, 2026.
The director confirmed there are no other material reasons for resignation beyond personal commitments.

💡 No immediate action is required as these are routine governance and administrative updates. Investors should monitor for the appointment of a new independent director to ensure continued board compliance.

Max India Q3 FY26: Revenue Grows 24% YoY to ₹43.1 Cr; Net Loss Narrows to ₹42.8 Cr

🔵 WATCH ⭐ 7/10

EARNINGS 📅 10 Feb 2026, 04:24 PM

Max India reported a 24% year-on-year increase in revenue from operations to ₹43.10 crore for the quarter ended December 31, 2025. Despite the revenue growth, the company continues to report significant losses, with a consolidated net loss of ₹42.85 crore for the quarter, slightly narrowing from ₹44.60 crore in the same period last year. A major concern remains the legal hurdle for its Noida project, where the company has paid ₹176 crore in dues to the Noida Authority but is still awaiting the Occupancy Certificate. Additionally, the company is in the process of closing its UK operations, which are no longer considered a going concern.

Consolidated Revenue from Operations rose 24% YoY to ₹43.10 crore in Q3 FY26.
Net Loss for the quarter stood at ₹42.85 crore, compared to a loss of ₹44.60 crore in Q3 FY25.
Paid ₹176 crore to Noida Authority to clear dues for the Antara Noida Phase I project.
Max UK Limited operations are being discontinued, with the going concern assumption no longer valid.
Next Supreme Court hearing regarding the Noida project's Occupancy Certificate is set for February 19, 2026.

💡 Investors should closely monitor the Supreme Court hearing on February 19, as the resolution of the Noida project's Occupancy Certificate is critical for cash flow. The stock remains a high-risk play given the persistent losses and regulatory hurdles in the senior living segment.

Max India Q3 FY26: Revenue Up 27% YoY to ₹49.8 Cr; EBITDA Loss Widens to ₹29 Cr

🟡 NEUTRAL ⭐ 7/10

EARNINGS 📅 10 Feb 2026, 04:17 PM

Max India reported a 27% YoY increase in consolidated revenue to ₹49.8 Cr for Q3 FY26, driven by growth across senior living and assisted care segments. However, the company remains in a gestation phase with an EBITDA loss of ₹29 Cr, slightly higher than the ₹26 Cr loss in the previous quarter. Real estate traction is robust, with the E360 Gurugram project 100% sold and the newly launched E361 project selling 100+ units within its first month. The company maintains a liquidity position of ₹105 Cr and a net worth of ₹426 Cr as of December 2025.

Consolidated revenue grew 27% YoY to ₹49.8 Cr, though EBITDA loss widened to ₹29 Cr from ₹24.7 Cr in the year-ago period.
E360 Gurugram project achieved 100% sales with a total value of ₹1,530 Cr and cumulative collections of ₹343 Cr.
Care Homes revenue surged 2.4x YoY to ₹5.0 Cr, supported by an operational capacity of 485 beds across NCR, Bengaluru, and Chennai.
AGEasy product segment revenue reached ₹18.8 Cr (up 1.5x YoY) with a gross margin of 41% and 5 patents filed for innovative products.
Antara Noida Phase 1 remains fully sold, with the company awaiting a positive court outcome for the Occupancy Certificate (OC).

💡 Investors should focus on the company's ability to narrow EBITDA losses as the senior living projects reach collection milestones and the assisted care business scales. Key triggers include the resolution of the Noida OC legal matter and the execution of the 1.5 million sq. ft. annual development target.

Max India Q3 FY26: Revenue Grows 24% YoY to ₹43.10 Cr; Net Loss at ₹42.85 Cr

🔵 WATCH ⭐ 7/10

EARNINGS 📅 10 Feb 2026, 04:08 PM

Max India reported a consolidated revenue of ₹43.10 crore for Q3 FY26, marking a 24% growth compared to ₹34.74 crore in the same period last year. Despite the revenue growth, the company remains in the red with a net loss of ₹42.85 crore for the quarter, primarily due to high operating expenses of ₹87.17 crore. A critical update involves its joint venture, Contend Builders, which has paid ₹176 crore to the Noida Authority to clear dues and is awaiting an Occupancy Certificate for the Antara Noida Phase I project. Furthermore, the company is winding down its UK operations, which are no longer treated as a going concern.

Consolidated revenue from operations increased 24% YoY to ₹43.10 crore in Q3 FY26.
Net loss for the quarter stood at ₹42.85 crore, slightly narrowing from ₹44.60 crore in Q3 FY25.
Joint Venture Contend Builders paid ₹176 crore to Noida Authority to resolve long-standing dues for the Noida project.
Max UK Limited operations are being discontinued following board approval for closure on May 30, 2025.
Marketing expenses saw a significant jump to ₹13.89 crore in Q3 FY26 from ₹11.29 crore YoY.

💡 Investors should closely track the February 19, 2026, Supreme Court hearing regarding the Noida project's Occupancy Certificate, as this is a major catalyst for the company's senior living business. While revenue is growing, the persistent losses and regulatory hurdles in Noida remain significant risks.

Max India's Antara Launches 72-Bed Senior Care Home in Chennai, Total Beds Reach 490

🟢 POSITIVE ⭐ 7/10

EXPANSION 📅 09 Feb 2026, 11:52 AM

Max India's subsidiary, Antara Senior Care, has expanded its footprint in Chennai with the launch of a new 72-bed assisted care facility on the OMR corridor. This is the company's second home in Chennai, a city where seniors constitute 14% of the population, the second-highest in India. With this launch, Antara now operates 8 facilities across India with a total capacity of approximately 490 beds. The expansion strategically positions the company to capture the rising demand for specialized geriatric and transition care in India's 'Health Capital'.

Launched a new 72-bed senior care facility in Chennai's OMR corridor.
Antara's total assisted care network grows to 8 facilities and approximately 490 beds across India.
Targets Tamil Nadu's aging demographic where 14% of the population is aged 60+.
Facility offers specialized long-term assisted living and short-term transition care services.
Strategically located near major medical infrastructure to serve post-acute patients.

💡 Investors should view this as a positive step in Max India's transition toward a service-led senior care model. Monitor occupancy levels and the ramp-up speed of these new facilities as they will be primary drivers of future revenue growth.

Max India Allots 60,000 Equity Shares Under ESOP Plan 2020

🟡 NEUTRAL ⭐ 3/10

ROUTINE 📅 09 Feb 2026, 11:20 AM

Max India Limited has approved the allotment of 60,000 equity shares to eligible employees under its Employee Stock Option Plan 2020. This allotment follows the exercise of vested stock options, increasing the company's total paid-up equity capital. The total number of shares has increased from 5,24,62,862 to 5,25,22,862. While this leads to a marginal equity dilution, it is a standard practice for employee retention and compensation.

Allotment of 60,000 equity shares of face value Rs. 10 each.
Paid-up capital increased from Rs. 52,46,28,620 to Rs. 52,52,28,620.
Total outstanding equity shares now stand at 5,25,22,862.
Allotment approved by the Nomination and Remuneration Committee on February 9, 2026.

💡 This is a routine administrative update with negligible impact on the company's valuation; no specific action is required from investors.

Max India's Antara Partners with SUD Life for Senior Care and Financial Products

🟢 POSITIVE ⭐ 6/10

EXPANSION 📅 04 Feb 2026, 09:43 AM

Max India's subsidiary, Antara Senior Care, has entered into a strategic partnership with Star Union Dai-ichi Life Insurance (SUD Life) to integrate senior wellness with financial security. The collaboration aims to address the needs of India's aging population, which is projected to grow from 156.7 million in 2024 to 347 million by 2050. Antara will leverage its experience of serving over 5 lakh seniors to provide specialized content and engagement, while SUD Life will launch exclusive financial products for Antara's customers. This partnership enhances Max India's ecosystem approach in the high-growth senior care sector.

Strategic tie-up to launch specialized financial products for seniors and raise awareness about integrated care.
Targeting a market where only 18% of seniors have health insurance and 78% live without pension cover.
India's senior population aged 80+ is projected to grow by approximately 279% between 2022 and 2050.
Antara's AGEasy platform has already touched over 5 lakh lives since its inception in 2023.
SUD Life brings a massive distribution network of 20,000 touchpoints and ₹31,069 crore in AUM.

💡 Investors should view this as a positive step towards scaling Antara's reach and diversifying its service offerings through cross-selling. Monitor the adoption rates of the new financial products as a lead indicator for deeper market penetration in the senior care segment.

Max India Allots 12,500 Equity Shares Under ESOP Plan 2020

🟡 NEUTRAL ⭐ 2/10

ROUTINE 📅 09 Jan 2026, 05:49 PM

Max India Limited has allotted 12,500 equity shares of face value Rs. 10 each to eligible employees following the exercise of vested stock options. This allotment was approved by the Nomination and Remuneration Committee on January 9, 2026, under the company's ESOP Plan 2020. Consequently, the paid-up equity capital has increased from Rs 52.45 crore to approximately Rs 52.46 crore. The dilution resulting from this issuance is minimal, representing roughly 0.02% of the total share capital.

Allotment of 12,500 equity shares of face value Rs 10 each to employees.
Total paid-up share capital increased to Rs 52,46,28,620 from Rs 52,45,03,620.
Total number of equity shares outstanding increased to 5,24,62,862.
The issuance was conducted under the Employee Stock Option Plan 2020.

💡 No action is required as this is a routine administrative allotment with negligible impact on earnings per share. Investors should focus on the company's operational performance in the senior living and healthcare sectors.

View All MAXIND Announcements on Live Market Tracking →

💰 Financial Performance

Revenue Growth by Segment

Consolidated revenue grew 15% YoY in H1 FY26 to INR 91.5 Cr. Antara Assisted Care Services (AACSL) revenue grew 76% (1.7x) to ~INR 44 Cr in FY25. AGEasy (launched 2023) scaled to INR 21.3 Cr in FY25 with an Annual Recurring Revenue (ARR) of INR 75 Cr. Care at Home achieved 400% growth over 4 years, reaching INR 17.23 Cr in FY25.

Geographic Revenue Split

While specific regional percentages are not disclosed, major contributions come from the Gurugram 'Estate 360' project, which achieved cumulative sales of 260 units and collected INR 239 Cr (94% efficiency), and the Dehradun facility which achieved breakeven ahead of plan with revenue at 109% of target.

Profitability Margins

AGEasy achieved a 23% contribution margin exit rate in September 2025. 64% of AGEasy products deliver a gross margin exceeding 50%. Care Homes target double-digit EBITDA margins once they reach 65-75% occupancy, typically 8-9 quarters post-launch.

EBITDA Margin

Consolidated EBITDA loss was INR 25.3 Cr in Q2 FY26 (approx -50% margin) compared to a loss of INR 15.7 Cr in Q2 FY25. FY25 consolidated EBITDA loss was INR 99.2 Cr (approx -60% margin) vs INR 34.3 Cr loss in FY24, driven by expansion costs in Care Homes and AGEasy scaling.

Capital Expenditure

The company raised INR 124.23 Cr through a rights issue in FY25 to fund AACSL growth. Invested capital in Senior Living (Residences) stood at INR 448 Cr as of September 2025. Liquidity of INR 208 Cr is earmarked for growth.

Credit Rating & Borrowing

Net debt of INR 105 Cr has been fully repaid. Finance costs increased 141% YoY to INR 4.1 Cr in Q2 FY26 from INR 1.7 Cr in Q2 FY25, reflecting increased utilization of credit for expansion before debt repayment.

⚙️ Operational Drivers

Raw Materials

Nutraceuticals (Gut Health range), senior care medical products (knee braces, diapers, nebulizers), and construction materials for senior living residences.

Import Sources

40% of sourcing for AGEasy products is currently from China to optimize gross margins.

Key Suppliers

Wellbeing Nutrition (Mumbai-based partner for Gut Health nutraceuticals).

Capacity Expansion

Targeting 500 operational beds in Assisted Care by November 2025. Planning to launch and sell 1.5 million square feet of senior residential units over the next 4 years.

Raw Material Costs

Not disclosed as a standalone percentage of revenue, but 40% sourcing from China is a key strategy to maintain the >50% gross margin seen in 64% of the AGEasy product portfolio.

Manufacturing Efficiency

Care Homes reach 40-50% occupancy within 4-5 quarters and 65-75% within 8-9 quarters. AGEasy marketing efficiency improved with RoAS (Return on Ad Spend) increasing to 2.9 in September 2025.

Logistics & Distribution

Flipkart marketplace now contributes 12-13% of AGEasy distribution.

📈 Strategic Growth

Expected Growth Rate

25%

Growth Strategy

Scaling AGEasy to reach breakeven by late FY27 or early FY28 through product expansion (14 new products in H1 FY26) and celebrity partnerships (Anupam Kher). Expanding Assisted Care footprint to 500 beds and executing a 1.5 million sq. ft. residential development pipeline.

Products & Services

Senior living residences (Estate 360), Care Homes (assisted living), Care at Home services, and AGEasy health products (nutraceuticals, mobility aids, and wellness interventions).

Brand Portfolio

Antara, AGEasy, Estate 360.

New Products/Services

Gut Health nutraceutical range launching Nov/Dec 2025 in partnership with Wellbeing Nutrition; 14 products launched in H1 FY26.

Market Expansion

Expansion of Assisted Care footprint across India; entering new markets with the AGEasy digital/product platform to reach seniors irrespective of geography.

Market Share & Ranking

Operates in a nascent market with 1.3% penetration; Max India is positioned as a first-mover in the organized 'Silver Economy' projected to reach USD 33 Bn by 2030.

Strategic Alliances

Partnership with Wellbeing Nutrition for nutraceuticals; celebrity partnerships with Anupam Kher and Hiten Tejwani for brand building.

🌍 External Factors

Industry Trends

The 'Silver Economy' is evolving from a nascent USD 13 Bn market (2024) to a projected USD 33 Bn market by 2030, driven by the rise of nuclear families and higher life expectancy. Max India is positioning itself as an integrated ecosystem (residences + care + products) to capture this 16.8% CAGR opportunity.

Competitive Landscape

Increasing competition as more players enter the rapidly evolving senior care sector, though Antara maintains high brand credibility.

Competitive Moat

Sustainable moat built through brand credibility (Max Group legacy), 4 product patents, and a specialized operational framework (800+ SOPs) that is difficult for new entrants to replicate quickly.

Macro Economic Sensitivity

High sensitivity to GDP growth and inflation, which influence consumer behavior in the premium senior care sector.

Consumer Behavior

Shift toward nuclear families and higher digital literacy among seniors is driving demand for organized home care and wellness products.

Geopolitical Risks

Trade barriers or supply chain issues with China could impact the 40% sourcing strategy for AGEasy.

⚖️ Regulatory & Governance

Industry Regulations

Subject to real estate development regulations (RERA) and healthcare service standards for Care Homes and Assisted Living facilities.

Taxation Policy Impact

Consolidated tax credit of INR 1.0 Cr reported in H1 FY26.

⚠️ Risk Analysis

Key Uncertainties

The capital-intensive nature of real estate development (INR 448 Cr invested) poses liquidity risks if project absorption slows. The 8-9 quarter timeline to EBITDA breakeven for Care Homes creates a long gestation period for profitability.